In May, Vitrolife announced that Bronwyn Brophy O'Connor had decided to step down as President and CEO to take up the same ...

AstraZeneca’s experimental cancer treatment sone-ve delivered longer survival than analysts had expected in a phase III trial ...

Medical device manufacturers will be spared duplicate certification processes to access the British market. The UK government ...

MEMBER ANNOUNCEMENT - Gruber A/S will join the Danish Pavilion at COMPAMED in Düsseldorf on 16–19 November 2026, with a focus ...

Eli Lilly’s advertising campaign about obesity did not breach industry rules on advertising aimed at the general public, ...

Biotech company Moderna fell nearly 18 percent on the stock market after study data on the company’s mRNA-based cancer ...

The Swedish medtech company Inossia, which is developing an additive for bone cement, has completed an oversubscribed SEK 88 ...

Pfizer has previously announced a major cost-cutting programme. Now, reports have emerged of job losses at several of the pharmaceutical giant's manufacturing sites in Europe and the US.

Based in Lund, Spago Nanomedical is developing Tumorad, a radionuclide therapy currently being evaluated in a Phase I study ...

A new treatment indication has opened up for AstraZeneca’s Ultomiris following positive results from a phase III trial. The ...

Swedish investment firm EQT is poised to make a major acquisition in the diagnostics sector with a 9.6 billion euro bid for ...

When AI is used both to write and screen job applications, it is becoming increasingly difficult to assess what candidates ...